BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Feb 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-18

Reporting Person: Ralls-Morrison Desiree (SVP, GC and Corp Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Deferred Stock Units	$	A	6819.0000	Acquired	2024-02-18	Common Stock (6819.0000)	Direct
2020-02-18	Stock Option (Right to Buy)	$42.1600	A	25442.0000	Acquired	2030-02-18	Common Stock (25442.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.